Oct 19 (Reuters) - Quest Diagnostics Inc ::Quest Diagnostics reports third quarter 2017 financial results, updates 2017 financial guidance and reaffirms long term outlook.qtrly adj earnings per share $1.39.q3 reported diluted eps of $1.15.Reports q3 revenue $1.93 billion.Reports q3 revenue up 2.4 percent.reaffirms long term outlook for 2017-2020.2017 cash provided by operations remains at approximately $1.2 billion.updates outlook for full year 2017 primarily due to financial impact of hurricanes and recently closed acquisitions in q3.2017 reported revenues now expected to be approximately $7.71 billion.continue to "urge" cms to delay implementation of protecting access to medicare act "to take time to get it right".2017 reported diluted eps now expected to be between $4.87 and $4.92.2017 adjusted diluted eps excluding amortization expense now expected to be between $5.62 and $5.67.Fy2017 earnings per share view $5.63, revenue view $7.69 billion -- Thomson Reuters I/B/E/S.Q3 earnings per share view $1.35, revenue view $1.92 billion -- Thomson Reuters I/B/E/S.
Oct 19 (Reuters) - Asian American Medical Group Ltd :FY revenue from ordinary activities down 11.2 percent to S$15.2 million .FY loss attributable S$3 million versus loss of S$2.1 mln.
Oct 19 (Reuters) - Top choice Medical Investment Co Inc <600763.SS>::Says it appoints Wang Yi, who is former CFO, as new general manager, replacing Lu Jianming .Co appoints Shou Yefei as new CFO .Lu Jianming will stay as chairman of the Board.
Oct 18 (Reuters) - HCA Healthcare Inc HCA.N:Sees Q3 2017 revenue $10.7 billion.net income attributable to HCA Healthcare Inc for Q3 is expected to approximate $426 million, or $1.15 per diluted share.HCA Healthcare Inc - anticipates revenues for Q3 of 2017 to approximate $10.696 billion compared to $10.270 billion in Q3 of 2016.HCA Healthcare - during Q3, incurred additional expenses and experienced losses of revenues estimated at about $140 million, or $0.24 per diluted share.HCA Healthcare - results for Q3 include a negative impact to operating results related to Texas Medicaid waiver program of approximately $50 million.HCA Healthcare - results for Q3 include negative impact to operating results related to Texas Medicaid waiver program of $0.08/diluted share.Sees FY 2017 updated revenues $43.0 billion to $44.0 billion.Sees 2017 EPS of $6.45 to $6.70 per diluted share.HCA Healthcare - same facility revenue per equivalent admission is expected to increase approximately 2.0 percent in Q3 compared to prior year's Q3.Q3 earnings per share view $1.57, revenue view $10.67 billion -- Thomson Reuters I/B/E/S.Sees FY 2017 updated capital expenditures approximately $3.0 billion.HCA Healthcare Inc - sees 2017 revenues $43.0 billion to $44.0 billion.HCA Healthcare Inc - sees 2017 EPS $6.45 to $6.70 per diluted share.FY2017 earnings per share view $7.11, revenue view $43.20 billion -- Thomson Reuters I/B/E/S.
Oct 18 (Reuters) - MEDNAX Inc ::MEDNAX ANNOUNCES ACQUISITION OF LEADING TEXAS RADIOLOGY PRACTICE.MEDNAX INC - NO ADDITIONAL TERMS OF TRANSACTION WERE DISCLOSED..MEDNAX INC - DEAL WAS A CASH AND EQUITY TRANSACTION AND IT IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO EARNINGS.MEDNAX INC - ACQUISITION OF SYNERGY RADIOLOGY ASSOCIATES, PA.MEDNAX INC - WITH ACQUISITION, 10 PHYSICIAN GROUP PRACTICES HAVE BECOME PART OF MEDNAX IN 2017.
Oct 18 (Reuters) - Pacific Smiles Group Ltd :Proposes restructure of Pacific Smiles Dental Centre located in Sydney's west.Proposed changes will result in a one-off EBITDA impact of $2.6 million in current period.Announces acquisition of 100 percent of everything dentures.Does not expect proposed restructure & acquisition to materially impact underlying performance of business in FY2018.
Oct 18 (Reuters) - Monash IVF Group Ltd ::Appoints David Morris as CEO and MD effective from 13 November 2017.
Oct 17 (Reuters) - Capio AB (publ) -:For full year 2017 Co's expectation is to reach a group EBIDTA growth of 5-7% compared to 2016 .Updated full year 2017 guidance and preliminary quarterly results for Capio group.Group EBIDTA result for q3 2017 was MSEK 168 (200), corresponding to a margin of 4.9% (6.3).
Oct 17 (Reuters) - Mediclinic International Plc :2017/18 INTERIM TRADING UPDATE.1H18 REVENUE WAS UP 9.5% AT GBP1.4BN (1H17: GBP1.3BN) .H1 UNDERLYING EBITDA WAS UP 5.0% AT GBP231M (1H17: GBP220M).H1 UNDERLYING EARNINGS PER SHARE IS EXPECTED TO BE AROUND 11.5 PENCE (1H17: 12.8 PENCE).TEAMS IN SOUTH AFRICA , SWITERLAND IMPLEMENTED COST SAVINGS PROGRAMMES, PRODUCTIVITY INITIATIVES TO HELP MARGINS DURING H2.NEW FACILITIES WILL REDUCE COST OF DEBT ON A LIKE FOR LIKE BASIS BY 25BPS AND EXTEND MATURITY PROFILE TO AT LEAST 2023.